Artemid supports Biotech Dental
The Artemid Senior Loan III fund is providing €20 million in financing that will enable the company to continue its international growth, particularly in the United States where the company has just acquired IDS, the last major independent distributor of dental implants.
Biotech Dental’s strategy is based on continuous innovation in both software and digital manufacturing processes.
This technological culture has enabled the group to build an offer of high quality products at affordable prices, 100% “Made in France”, in their manufacturing centers in the Arve Valley (Rhône-Alpes) and Salon-de-Provence, where its head office is also located.
The funds in the Artemid range are managed by the asset management company CAPZA as well as a third party portfolio management company and advised by Artemid SAS, a joint subsidiary of CAPZA and Amiral Gestion. Artemid SAS is a financial investment advisor (conseiller en investissement financier – CIF) registered at the ORIAS under the number 14003497 since 5/28/2014.
-
22Oct’ 2025CAPZA successfully exits Magellan PartnersCAPZA announces its exit from Magellan Partners, after supporting the Group’s growth strategy since 2021.Read more -
9Oct’ 2025An introduction to the European Flex Equity marketDiscover our latest White Paper on Flex Equity.Read more -
17Sep’ 2025CAPZA acquires a minority stake in BeetweenCAPZA has acquired a minority stake in Beetween, a leading European provider of recruitment software solutions.Read more -
15Sep’ 2025Artemid supports SNIC Technologies’ growth strategyArtemid co-arranges a senior debt financing to accelerate SNIC Technologies’ expansion in Europe.Read more